|
2019
|
Invention
|
Method of providing pirfenidone therapy to a patient.
The invention relates to methods for decre... |
|
|
Invention
|
Methods of administering pirfenidone therapy.
The present invention relates to methods involving... |
|
|
Invention
|
Pirfenidone treatment for patients with atypical liver function.
Methods are provided for admini... |
|
|
Invention
|
Methods of administering pirfenidone therapy.
The disclosure relates to improved methods of admi... |
|
2016
|
Invention
|
Method of modulating stress-activated protein kinase system. Disclosed are methods of modulating ... |
|
|
Invention
|
Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone. ... |
|
|
Invention
|
Lpa-associated protein and rna expression.
Provided herein are, inter alia, methods and biomarke... |
|
2015
|
Invention
|
Method for synthesizing pirfenidone.
A process for synthesizing pirfenidone from bromobenzene ha... |
|
|
Invention
|
Pirfenidone therapy and inducers of cytochrome p450.
The present invention relates to methods in... |
|
|
Invention
|
Lpa-associated protein and rna expression. Provided herein are, inter alia, methods and biomarker... |
|
|
Invention
|
Anti-fibrotic pyridinones. This application relates to polycyclic compounds with a pyridinone or ... |
|
|
Invention
|
Pharmaceutical composition containing as an active ingredient 5-methyl -1-phenyl-2-(1h)-pyridone.... |
|
2014
|
Invention
|
Compounds and methods for treating inflammatory and fibrotic disorders. Disclosed are compounds a... |
|
|
Invention
|
Method for preparing a granulate formulation of pirfenidone and pharmaceutically acceptable excip... |
|
|
Invention
|
Altering pharmacokinetics of pirfenidone therapy.
The invention relates to methods for reducing ... |
|
|
Invention
|
Proteomic ipf markers. Provided herein are novel biomarkers for the identification, prediction or... |
|
|
Invention
|
Methods of improving microvascular integrity. The disclosure relates to methods of preserving or ... |
|
|
Invention
|
Lysophosphatidic acid receptor antagonists.
Compounds, methods of making such compounds, pharmac... |
|
|
Invention
|
Lysophosphatidic acid receptor antagonists. Compounds, methods of making such compounds, pharmace... |
|
2013
|
Invention
|
Anti-fibrotic pyridinones. Disclosed are pyridinone compounds, method for preparing these compoun... |
|
|
Invention
|
Methods of administering pirfenidone therapy. The disclosure relates to improved methods of admin... |
|
|
Invention
|
Anti-fibrotic pyridinones.
Disclosed are pyridinone compounds, method for preparing these compou... |
|
2012
|
Invention
|
Pirfenidone and anti-fibrotic therapy in selected patients.
The present invention relates to met... |
|
2001
|
G/S
|
Pharmaceutical substances and preparations for the treatment of immunological disorders, namely, ... |
|
1998
|
G/S
|
Pharmaceutical and veterinary substances and preparations; diagnostic kits and reagents for clini... |
